News
Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery (MBS) use among US adolescents increased from 2021 to 2023.
Last month, the scientists behind Ozempic – hailed as a ‘miracle drug’ for weight-loss – were honoured by the Breakthrough Prize for Life Sciences, which awarded the five drug developers with $3 ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...
Explore more
Home Online Features What You Need to Know About GLP-1 Weight-Loss Drugs Now That the FDA Says the Shortage Is Over Community ...
As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth.” The term refers to a range of dental issues users have reportedly been experiencing — such as dry mouth, bad ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.
Chronic alcohol use depletes nutrients—and poor nutrition increases risk for alcohol dependence. Learn how diet, brain chemistry, and gut health create a self-reinforcing cycle.
Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results